The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Socioeconomic factors behind survival disparities in EGFR-m NSCLC treatment
Matthew Lee, MD, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, comments on socioeconomic factors behind disparities between patients with EGFR-mutated non-small cell lung cancer (NSCLC) treated with osimertinib. Insurance and income were two factors that may contribute to differences in overall survival outcomes between non-Hispanic Black and non-Hispanic Whites. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
